PS Ratio Chart

Historical PS Ratio Data

View and export this data back to 1996. Start Trial.
Date Value
October 02, 2026 2.540
October 01, 2026 2.553
September 30, 2026 2.592
September 29, 2026 2.611
September 28, 2026 2.654
September 25, 2026 2.611
September 24, 2026 2.555
September 23, 2026 2.540
September 22, 2026 2.586
September 21, 2026 2.602
September 18, 2026 2.620
September 17, 2026 2.611
September 16, 2026 2.642
September 15, 2026 2.648
September 14, 2026 2.663
September 11, 2026 2.644
September 10, 2026 2.648
September 09, 2026 2.676
September 08, 2026 2.688
September 04, 2026 2.776
September 03, 2026 2.829
September 02, 2026 2.811
September 01, 2026 2.780
August 31, 2026 2.776
August 28, 2026 2.766
Date Value
August 27, 2026 2.781
August 26, 2026 2.807
August 25, 2026 2.822
August 24, 2026 2.795
August 21, 2026 2.784
August 20, 2026 2.720
August 19, 2026 2.809
August 18, 2026 2.744
August 17, 2026 2.685
August 14, 2026 2.652
August 13, 2026 2.686
August 12, 2026 2.646
August 11, 2026 2.643
August 10, 2026 2.694
August 07, 2026 2.689
August 06, 2026 2.665
August 05, 2026 2.643
August 04, 2026 2.737
August 03, 2026 2.720
July 31, 2026 2.713
July 30, 2026 2.694
July 29, 2026 2.621
July 28, 2026 2.642
July 27, 2026 2.599
July 24, 2026 2.580

Price to Sales Ratio Definition

The Price to Sales Ratio (PS Ratio) is calculated by taking the stock price / revenue per share (ttm). This metric is considered a valuation metric that confirms whether the sales of a company justifies the stock price. There isn't necesarily an optimum PS ratio, since different industries will have different ranges of PS Ratios. Because of this, PS Ratio is great to evaluate from a relative standpoint with other similar companies. PS Ratio might also be a handy metric for companies that are not profitable yet, since they might be valued moreso by their overall sales and potential of becoming profitable in the future.

Read full definition.

PS Ratio Range, Past 5 Years

View PS Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

PS Ratio Benchmarks

View PS Ratio Benchmarks
Start Trial
Johnson & Johnson 6.374
Eli Lilly & Co. 13.03
Merck & Co., Inc. 5.403
Pfizer Inc. 2.491
AstraZeneca PLC 8.100

PS Ratio Related Metrics